OGDEN CHRISTOPHER (See Remarks) received a stock award from CYTOMX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/6/2025ACC: 0001610717-25-000017
Officer· See Remarks
Since Feb 2022
+441.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
441.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+44K
Price / share
—
Trade value
—
% of position
40.7%
2/4/2025
108.08K→152.08K
Common Stock
Direct
Shares
+57.50K
Price / share
—
Trade value
—
% of position
37.8%
2/4/2025
152.08K→209.58K
Total
Net shares
+101.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | A · Award | +44K | — | — | 40.7% | 108.08K | 152.08K |
| Common Stock Direct | 2/4/2025 | A · Award | +57.50K | — | — | 37.8% | 152.08K | 209.58K |
| Total | +101.50K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
225K shares
Shares
+225K
Strike price
0.864
Held after
225K
Exercisable
—
2/4/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
115K shares
Shares
+115K
Strike price
0.864
Held after
115K
Exercisable
—
2/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock225K shares | 2/4/2025 | A · Award | +225K | 0.864 | — | 225K |
| Stock Option (Right to Buy) Direct | Common Stock115K shares | 2/4/2025 | A · Award | +115K | 0.864 | — | 115K |